Literature DB >> 3707104

Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy.

E J Goldstein, D M Citron, A E Vagvolgyi, S M Finegold.   

Abstract

The susceptibility of 93 aerobic and 59 anaerobic bacteria isolated from human and animal bite wounds was determined by agar dilution. No agent tested (penicillin, oxacillin, cephalexin, sulfamethoxazole-trimethoprim, minocycline, erythromycin, and RU-965) was consistently active against all isolates. A total of 21% of the Bacteroides species, all isolated from human bites, were resistant to penicillin; 14 and 18% of the Pasteurella multocida isolates were resistant to erythromycin and oxacillin, respectively.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3707104      PMCID： PMC180440          DOI： 10.1128/AAC.29.4.556

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Prophylactic antibiotics in common dog bite wounds: a controlled study.

Authors:  M Callaham
Journal:  Ann Emerg Med       Date:  1980-08       Impact factor: 5.721

Review 2.  Role of anaerobic bacteria in bite-wound infections.

Authors:  E J Goldstein; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

Review 3.  Pasteurella multocida infections. Report of 34 cases and review of the literature.

Authors:  D J Weber; J S Wolfson; M N Swartz; D C Hooper
Journal:  Medicine (Baltimore)       Date:  1984-05       Impact factor: 1.889

4.  Bacteriology of human and animal bite wounds.

Authors:  E J Goldstein; D M Citron; B Wield; U Blachman; V L Sutter; T A Miller; S M Finegold
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

5.  Unidentified gram-negative rod infection. A new disease of man.

Authors:  T Butler; R E Weaver; T K Ramani; C T Uyeda; R A Bobo; J S Ryu; R B Kohler
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

6.  Dog bite wounds and infection: a prospective clinical study.

Authors:  E J Goldstein; D M Citron; S M Finegold
Journal:  Ann Emerg Med       Date:  1980-10       Impact factor: 5.721

7.  Prophylactic oxacillin in dog bite wounds.

Authors:  R M Elenbaas; W K McNabney; W A Robinson
Journal:  Ann Emerg Med       Date:  1982-05       Impact factor: 5.721

8.  Eikenella corrodens in hand infections.

Authors:  E J Goldstein; M F Barones; T A Miller
Journal:  J Hand Surg Am       Date:  1983-09       Impact factor: 2.230

9.  Treatment of common dog bites: infection risk factors.

Authors:  M L Callaham
Journal:  JACEP       Date:  1978-03

10.  Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191
View more
  9 in total

Review 1.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

Authors:  E J Goldstein; D M Citron; G A Richwald
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

4.  Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen.

Authors:  D A Talan; D Staatz; A Staatz; E J Goldstein; K Singer; G D Overturf
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

5.  In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida.

Authors:  E Holst; J Rollof; H Miörner
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  Management of human and animal bite wound infection: an overview.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

7.  Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; C A Nesbit; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

Review 9.  Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  R A Young; J P Gonzalez; E M Sorkin
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.